Literature DB >> 29025374

The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Hyunjin Park1, Yangkyu Lee2, Hyejung Lee1, Jin-Won Kim3, Jin-Hyeok Hwang3, Jaihwan Kim3, Yoo-Seok Yoon4, Ho-Seong Han4, Haeryoung Kim1.   

Abstract

Cancer-associated fibroblasts are abundant in the desmoplastic stroma of pancreatic ductal adenocarcinomas and are considered to play important roles in tumor progression. In this study, we investigated the expression status of secreted protein acidic and rich in cysteine, periostin, fibroblast-activated protein, and the newly developed proCOL11A1 antibody in the stroma of surgically resected pancreatic ductal adenocarcinomas and their prognostic implications. Tissue microarrays were constructed from 155 surgically resected pancreatic ductal adenocarcinomas and paired non-neoplastic pancreata and from another independent set of 48 normal/benign pancreata, and immunohistochemical stains were performed for proCOL11A1, fibroblast-activated protein, secreted protein acidic and rich in cysteine, and periostin. The immunohistochemical stain results were correlated with clinicopathological features and survival data. proCOL11A1, fibroblast-activated protein, secreted protein acidic and rich in cysteine, and periostin expression was significantly increased in the intratumoral stroma of pancreatic ductal adenocarcinomas compared to paired non-neoplastic pancreata (proCOL11A1: 145/155 (93.5%) vs 26/154 (16.9%); fibroblast-activated protein: 139/143 (97.2%) vs 82/132 (62.1%); secreted protein acidic and rich in cysteine: 113/150 (75.3%) vs 49/132 (37.1%); periostin: 135/151 (89.4%) vs 45/135 (33.3%); p < 0.001, all). While the four markers were expressed at lower levels in normal/benign pancreata, there were no significant differences in the expression frequencies among normal pancreas, acute pancreatitis, and chronic pancreatitis. Interestingly, on survival analysis, low intratumoral fibroblast-activated protein+ cancer-associated fibroblast counts (<100/high-power field) were associated with a significantly reduced overall survival compared to those with high fibroblast-activated protein+ cancer-associated fibroblast counts (p = 0.010; hazard ratio 5.2 (95% confidence interval 1.3-21.3)). Similar patterns were seen for proCOL11A and secreted protein acidic and rich in cysteine and overall and disease-free survival, although not statistically significant. In conclusion, we demonstrate that the presence of cancer-associated fibroblasts in the tumor stroma may not always be associated with a poor prognosis as suggested in many studies; on the contrary, it may even be associated with prolonged survival, supporting the recent experimental findings that tumor stroma may have a protective role rather than enhance aggressive behavior.

Entities:  

Keywords:  Pancreatic ductal adenocarcinoma; cancer-associated fibroblast; fibroblast-activated protein; periostin; proCOL11A1; prognosis; secreted protein acidic and rich in cysteine

Mesh:

Substances:

Year:  2017        PMID: 29025374     DOI: 10.1177/1010428317718403

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  11 in total

Review 1.  The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.

Authors:  Yohei Masugi
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

Review 2.  The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer.

Authors:  Qiqing Sun; Bo Zhang; Qiangsheng Hu; Yi Qin; Wenyan Xu; Wensheng Liu; Xianjun Yu; Jin Xu
Journal:  Theranostics       Date:  2018-10-06       Impact factor: 11.556

3.  Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.

Authors:  Cindy Neuzillet; Annemilaï Tijeras-Raballand; Chanthirika Ragulan; Jérôme Cros; Yatish Patil; Matthieu Martinet; Mert Erkan; Jörg Kleeff; Jeremy Wilson; Minoti Apte; Marie Tosolini; Abigail S Wilson; Francesca R Delvecchio; Corinne Bousquet; Valérie Paradis; Pascal Hammel; Anguraj Sadanandam; Hemant M Kocher
Journal:  J Pathol       Date:  2019-02-22       Impact factor: 7.996

4.  TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts.

Authors:  Angelo L Grauel; Beverly Nguyen; David Ruddy; Tyler Laszewski; Stephanie Schwartz; Jonathan Chang; Julie Chen; Michelle Piquet; Marc Pelletier; Zheng Yan; Nathaniel D Kirkpatrick; Jincheng Wu; Antoine deWeck; Markus Riester; Matt Hims; Felipe Correa Geyer; Joel Wagner; Kenzie MacIsaac; James Deeds; Rohan Diwanji; Pushpa Jayaraman; Yenyen Yu; Quincey Simmons; Shaobu Weng; Alina Raza; Brian Minie; Mirek Dostalek; Pavitra Chikkegowda; Vera Ruda; Oleg Iartchouk; Naiyan Chen; Raphael Thierry; Joseph Zhou; Iulian Pruteanu-Malinici; Claire Fabre; Jeffrey A Engelman; Glenn Dranoff; Viviana Cremasco
Journal:  Nat Commun       Date:  2020-12-09       Impact factor: 14.919

5.  Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts.

Authors:  Kongzhen Hu; Junqi Li; Lijuan Wang; Yong Huang; Li Li; Shimin Ye; Yanjiang Han; Shun Huang; Hubing Wu; Jin Su; Ganghua Tang
Journal:  Acta Pharm Sin B       Date:  2021-10-15       Impact factor: 11.413

6.  COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.

Authors:  Yi-Hui Wu; Yu-Fang Huang; Tzu-Hao Chang; Chien-Chin Chen; Pei-Ying Wu; Soon-Cen Huang; Cheng-Yang Chou
Journal:  Oncogene       Date:  2021-06-11       Impact factor: 9.867

7.  Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma.

Authors:  Christopher Hartley; Daniel Rowan; Xiuxu Chen; Luisa Gomez-Arellano; Anna Marie West; Kiyoko Oshima; Alexander Craig Mackinnon
Journal:  Pract Lab Med       Date:  2020-05-29

Review 8.  Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy.

Authors:  Dhruba Kadel; Yu Zhang; Hao-Ran Sun; Yue Zhao; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cell Biol Toxicol       Date:  2019-01-24       Impact factor: 6.691

9.  miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.

Authors:  Yi-Hui Wu; Yu-Fang Huang; Tzu-Hao Chang; Pei-Ying Wu; Tsung-Ying Hsieh; Sheng-Yen Hsiao; Soon-Cen Huang; Cheng-Yang Chou
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

10.  COL11A1-Driven Epithelial-Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail Pathway.

Authors:  Hui Wang; Huichao Zhou; Hong Ni; Xiaohong Shen
Journal:  Biomolecules       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.